missing translation for 'onlineSavingsMsg'
Få mere at vide
Få mere at vide
Amikacin, MP Biomedicals™
Shop alle MP Biomedicals produkter
missing translation for 'orderingAttributeHoverText'
Quantity:
250 mg
Förpackningsstorlek
250mg
Beschreibung
Amikacin works by binding to the bacterial 30S ribosomal subunit, inducing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth. It interferes with the translocation of tRNA from the A-site to the P-site. Amikacin must be given by the intravenous or intramuscular route; it is not absorbed orally.
Spezifikation
Spezifikation
| Physical Form | Powder |
| CAS | 37517-28-5 |
| pH | 9.5 to 11.5 (1% aq. soln.) |
| Potency | ca. 900μg/mg |
| Quantity | 250 mg |
| Optical Rotation | 100.5° |
| Molecular Formula | C22H43N5O13 |
| Boiling Point | 981.8°C (760mmHg) |
| Synonym | 1-N-[L(-)-4-Amino-2-hydroxy-butyryl] kanamycin A, O-3-Amino-3-deoxy-a -D-glucopyranosyl-(1 ---> 6)-O-6-amino-6-deoxy-a-D-glucopyranosyl-(1 ---> 4)]- N1 -(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-D-streptamine, Lukadin |
| Solubility Information | Sparingly soluble in water. |
| Mehr anzeigen |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur